Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized trial of orismilast in moderate-to-severe plaque psoriasis
2021-003209-22Phase 2Completed
- Sponsor
- UNION therapeutics
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of orismilast in plaque psoriasis (5 arms), sponsored by UNION therapeutics. Started Oct 2021; status: completed.
02
Drugs
orismilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2021-003209-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003209-22.